Ashleigh is Regulatory Strategy Principal (UK) at TÜV SÜD where she ensures the organisation stays abreast of emerging regulatory requirements and represents TÜV SÜD within the wider regulatory network. Ashleigh previously held roles at BIVDA (the British In Vitro Diagnostic Association) liaising directly with the IVD industry, and at MHRA (the Medicines and Healthcare products Regulatory Agency) contributing to policy development.
Throughout her regulatory career, Ashleigh has developed a keen interest in UK regulations for medical devices and IVDs and has remained close to the ongoing evolution of new legislation. Additionally, her involvement in the EU has provided a strong knowledge of EU MDR and EU IVDR requirements.